Hony Capital trims stake in CSPC Pharmaceutical by $154 million

The upsized deal comes at a 10.2% discount and will open the door for the private equity firm to convert part of an $860 million CB following a surge in the share price.

Hony Capital trims stake in CSPC Pharmaceutical by $154 million

A company controlled by Chinese private equity firm Hony Capital last night sold part of its stake in Hong Kong-listed CSPC Pharmaceutical, raising HK$1.2 billion $154 million.

While it didn’t spell it out directly, the sale is likely to have been prompted by a desire to convert some of its CSPC Pharma convertible bonds after the share price has rallied 80% this year. According to the conditions, the CB can only be converted...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition

EVENTS